Sajid A Khan MD FACS
Hepatobiliary Surgery, Melanoma, Pancreas, Surgical Oncology (Other than Breast)
Associate Professor of Surgery, Yale University School of Medicine; Chief, Section of Hepato-Pancreato-Biliary & Mixed Tumors; Co-Director of Team Science, Yale Center for Clinical Investigation; Co-Director Hepatic Arterial Infusion Pump Program; Co-Leader Advanced Hepatobiliary Disease
Join to View Full Profile
Yale Surgery - Gastrointestinal/OncologyPO BOX 208062New Haven, CT 06520
Phone+1 203-337-8507
Fax+1 203-330-7461
Dr. Khan is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Sajid Khan is a general surgeon specializing in hepatobiliary surgery, melanoma, pancreas, and surgical oncology, based in New Haven, CT. He completed his medical education from SUNY Upstate Medical University and underwent extensive surgical training, including fellowships at University of Chicago and Memorial Sloan Kettering Cancer Center. He serves as Section Chief of Hepato-Pancreato-Biliary and Mixed Tumors, Co-Director of the Hepatic Arterial Pump Program, Co-Leader of Advanced Hepatobiliary Disease, and Co-Director of Team Science at Yale School of Medicine and holds various roles at Yale New Haven Health System, Yale Cancer Center, and Yale School of Medicine. Dr. Khan has published research on surgical oncology, and was recognized as a Regional Top Doctor by Castle Connolly from 2015 to 2025. His clinical expertise encompasses cholangiocarcinoma, liver metastasis, pancreatic cancer, neuroendocrine tumors, gastric cancers, soft tissue sarcomas, and surgical oncology.
Clinical Expertise
- Cholangiocarcinoma, Soft tissue sarcomas, Gastrectomy, Surgical oncology (non-breast), Colorectal surgery, Pancreatectomy, Hepatectomy, Genomics, Health outcomes research, Neoplasm staging, Metabolomics, Metastasis, Minimally Invasive Surgical Procedures, RNA
Education & Training
Yale School of ManagementExecutive Program, Emerging Leaders Program, 2019 - 2021- American College of Surgeons, Division of EducationLeadership, Surgeons as Leaders: From Operating Room to Boardroom, 2016 - 2016
University of ChicagoFellowship, Complex General Surgical Oncology, 2010 - 2013
Oregon Health & Science University (OHSU Health)Residency, Surgery, 2007 - 2010
Memorial Sloan Kettering Cancer CenterFellowship, Complex General Surgical Oncology, 2005 - 2007
Montefiore Medical Center/Albert Einstein College of MedicineResidency, Surgery, 2004 - 2005- Montefiore Medical Center/Albert Einstein College of MedicineInternship, Surgery, 2003 - 2004
SUNY Upstate Medical UniversityClass of 2003- Siena CollegeBS, Biology , 1995 - 1999
Certifications & Licensure
OR State Medical License 2009 - Present
CT State Medical License 2013 - 2026
IL State Medical License 2010 - 2014
American Board of Surgery Surgery- American Board of Surgery Complex General Surgical Oncology
Awards, Honors, & Recognition
- Regional Top Doctors Castle Connolly, 2014-2025
Publications & Presentations
PubMed
- Biliary Tract Cancers, Version 2.2025, NCCN Clinical Practice Guidelines In Oncology.Al B Benson 3rd, Michael I D'Angelica, Thomas Abrams, Aijaz Ahmed, Mehmet Akce
Journal of the National Comprehensive Cancer Network. 2025-09-01 - Distinct metabolic and genetic alterations in tumors from early-onset versus late-onset colorectal cancer.Allison Janak, Abhishek Jain, Rolando Garcia-Milian, Oladimeji Aladelokun, Xiaomei Ma
Free Radical Biology & Medicine. 2025-08-25 - Procedural Physician-Scientists as Catalysts for Innovation in Team Science and Clinical Care.Sajid A Khan, Kurt S Schultz, Nita Ahuja
Cancers. 2025-07-25
Press Mentions
United by Cancer Research: One Mission. One VoiceMay 28th, 2025- Yale Surgeons to Present at International Surgical Oncology ConferenceMarch 24th, 2025
- Immunotherapy May Be Overused in Dying Patients with CancerAugust 8th, 2024
- Join now to see all
Grant Support
- Role and regulation of asparagine in colorectal cancerNational Institutes of Health2025–2029
- Role of immune regulation in colorectal cancer chemotherapeutic responseNational Institutes of Health2021–2026
- Identification of metabolic niches in colorectal cancerNational Institutes of Health2023–2025
- Understanding sex differences in colon cancer metabolismNational Institutes of Health2018–2020
Professional Memberships
- Fellow
- Member
- Americas Hepato-Pancreato-Biliary AssociationMember
- Member
- Fellow
- Southwest Oncology GroupMember
- National Comprehensive Cancer Network - NCCNMember
- Surgical Biology ClubMember
- Society of University SurgeonsMember
- Annals of Surgical OncologyEditorial Board
- Journal of the American Medical Association (JAMA) OncologyEditorial Board
- Indian Journal of SurgeryEditorial Board
Other Languages
- Urdu, Arabic
External Links
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
